Skip to main content
Top
Published in: Journal of Neurology 11/2015

01-11-2015 | Original Communication

Association of depressive symptoms with circadian blood pressure alterations in Parkinson’s disease

Authors: Davide L. Vetrano, Maria S. Pisciotta, Maria R. Lo Monaco, Graziano Onder, Alice Laudisio, Vincenzo Brandi, Domenico La Carpia, Mauro Guglielmo, Antonio Nacchia, Domenico Fusco, Diego Ricciardi, Anna R. Bentivoglio, Roberto Bernabei, Giuseppe Zuccalà

Published in: Journal of Neurology | Issue 11/2015

Login to get access

Abstract

To assess whether among patients with Parkinson’s disease (PD) depression, a common non-motor symptom associated with reduced survival, is associated with cardiovascular dysautonomia. We enrolled 125 subjects with PD consecutively admitted to a geriatric day hospital. All participants underwent comprehensive evaluation, fasting blood sampling, and 24-h ambulatory blood pressure monitoring. The percent reduction in nocturnal blood pressure (dipping) was calculated. Depressive symptoms were assessed through the 15-item Geriatric Depression Scale (GDS); a score ≥5 identified moderate to severe symptoms. Among participants (mean age 72.7 ± 7.8 years, 32 % women) 61 subjects (49 %) presented with a GDS score ≥ 5. When compared with other participants, subjects with a GDS score ≥ 5 had reduced adjusted levels of percent systolic (−2.6 ± 2.7 vs. 4.7 ± 2.5; p = 0.003), diastolic (0.6 ± 2.8 vs. 7.4 ± 2.6; p = 0.007), and mean blood pressure dipping (−0.7 ± 2.6 vs. 6.8 ± 2.5; p = 0.002). In separate logistic regression models, depressive symptoms were associated with reduced systolic (OR 0.94; 95 % CI 0.89; 0.98), diastolic (OR 0.94; 95 % CI 0.90; 0.99), and mean blood pressure dipping (OR 0.93; 95 % CI 0.89; 0.98), after adjusting for potential confounders. Depressive symptoms are prevalent, and independently associated with cardiovascular dysautonomia among patients with Parkinson’s disease. This might explain the remarkable incidence of sudden death, as well as the association of depressive symptoms with reduced survival reported in these patients. The finding of depressive symptoms in subjects with Parkinson’s disease should therefore prompt assessment of cardiovascular autonomic function.
Literature
1.
go back to reference Velseboer DC, Broeders M, Post B et al (2013) Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD. Neurology 80(7):627–633CrossRefPubMed Velseboer DC, Broeders M, Post B et al (2013) Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD. Neurology 80(7):627–633CrossRefPubMed
2.
go back to reference Barone P, Antonini A, Colosimo C et al (2009) PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649. doi:10.1002/mds.22643 CrossRefPubMed Barone P, Antonini A, Colosimo C et al (2009) PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649. doi:10.​1002/​mds.​22643 CrossRefPubMed
5.
go back to reference Dickson DW, Fujishiro H, Orr C et al (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15(Suppl 3):S1–S5CrossRefPubMed Dickson DW, Fujishiro H, Orr C et al (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15(Suppl 3):S1–S5CrossRefPubMed
6.
go back to reference Asahina M, Vychanrat E, Low DA et al (2013) Autonomic Dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurolg Neurosurg Psychiatry 84(6):674–680CrossRef Asahina M, Vychanrat E, Low DA et al (2013) Autonomic Dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurolg Neurosurg Psychiatry 84(6):674–680CrossRef
9.
go back to reference Hughes TA, Ross HF, Mindham RH et al (2004) Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurol Scand 110(2):118–123CrossRefPubMed Hughes TA, Ross HF, Mindham RH et al (2004) Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurol Scand 110(2):118–123CrossRefPubMed
10.
go back to reference Sagna A, Gallo JJ, Pontone GM (2014) Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord 20:708–715CrossRefPubMed Sagna A, Gallo JJ, Pontone GM (2014) Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord 20:708–715CrossRefPubMed
11.
go back to reference Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. JNNP 55:181–184 Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. JNNP 55:181–184
12.
go back to reference Almeida OP, Almeida SA (1999) Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 14(10):858–865CrossRefPubMed Almeida OP, Almeida SA (1999) Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 14(10):858–865CrossRefPubMed
13.
go back to reference Friedman B, Heisel MJ, Delavan RL (2005) Psychometric properties of the 15-item geriatric depression scale in functionally impaired, cognitively intact, community-dwelling elderly primary care patients. J Am Geriatr Soc 53(9):1570–1576CrossRefPubMed Friedman B, Heisel MJ, Delavan RL (2005) Psychometric properties of the 15-item geriatric depression scale in functionally impaired, cognitively intact, community-dwelling elderly primary care patients. J Am Geriatr Soc 53(9):1570–1576CrossRefPubMed
14.
go back to reference Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRefPubMed Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRefPubMed
15.
go back to reference Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022CrossRef Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157(11):1015–1022CrossRef
16.
go back to reference Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792CrossRefPubMed Berrios GE, Campbell C, Politynska BE (1995) Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 166:789–792CrossRefPubMed
19.
20.
go back to reference Remy P, Doder M, Lees A et al (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314–1322CrossRefPubMed Remy P, Doder M, Lees A et al (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314–1322CrossRefPubMed
22.
23.
go back to reference Rektorova I, Rektor I, Bares M et al (2013) Pramipexole and Pergolide in treatment of depression in Parkinson’s disease: a national multicentre prospective randomized study. Eur J Neurol 10(4):399–406CrossRef Rektorova I, Rektor I, Bares M et al (2013) Pramipexole and Pergolide in treatment of depression in Parkinson’s disease: a national multicentre prospective randomized study. Eur J Neurol 10(4):399–406CrossRef
24.
go back to reference Braak H, Ghebremedhin E, Rüb U et al (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134CrossRefPubMed Braak H, Ghebremedhin E, Rüb U et al (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134CrossRefPubMed
26.
go back to reference Drago S, Bergerone S, Anselmino M et al (2007) Depression in patients with acute myocardial infarction: influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study. Int J Cardiol 115(1):46–51CrossRefPubMed Drago S, Bergerone S, Anselmino M et al (2007) Depression in patients with acute myocardial infarction: influence on autonomic nervous system and prognostic role. Results of a five-year follow-up study. Int J Cardiol 115(1):46–51CrossRefPubMed
28.
go back to reference Ishizaki F, Harada T, Yoshinaga H et al (1996) Prolonged QTc intervals in Parkinson’s disease–relation to sudden death and autonomic dysfunction. No To Shinkei 48(5):443–448PubMed Ishizaki F, Harada T, Yoshinaga H et al (1996) Prolonged QTc intervals in Parkinson’s disease–relation to sudden death and autonomic dysfunction. No To Shinkei 48(5):443–448PubMed
30.
go back to reference Murata Y, Harada I, Ishizaki F et al (1997) Autonomic dysfunction in Parkinson’s disease and vascular parkinsonism. Acta Neurol Scand 96:359–365CrossRefPubMed Murata Y, Harada I, Ishizaki F et al (1997) Autonomic dysfunction in Parkinson’s disease and vascular parkinsonism. Acta Neurol Scand 96:359–365CrossRefPubMed
31.
go back to reference Vriend C, Raijmakers P, Veltman DJ et al (2014) Depressive symptoms in Parkinson’s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85(2):159–164. doi:10.1136/jnnp-2012-304811 CrossRefPubMed Vriend C, Raijmakers P, Veltman DJ et al (2014) Depressive symptoms in Parkinson’s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85(2):159–164. doi:10.​1136/​jnnp-2012-304811 CrossRefPubMed
Metadata
Title
Association of depressive symptoms with circadian blood pressure alterations in Parkinson’s disease
Authors
Davide L. Vetrano
Maria S. Pisciotta
Maria R. Lo Monaco
Graziano Onder
Alice Laudisio
Vincenzo Brandi
Domenico La Carpia
Mauro Guglielmo
Antonio Nacchia
Domenico Fusco
Diego Ricciardi
Anna R. Bentivoglio
Roberto Bernabei
Giuseppe Zuccalà
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 11/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7887-0

Other articles of this Issue 11/2015

Journal of Neurology 11/2015 Go to the issue